menu
Presentation
October 22, 2019

Interpretation and Application of the 2018 FDA Guidance on Bioanalytical Method Validation 

2019 PBSS San Francisco Bay Presentation
Regulated bioanalysis (RBA) is required in the key parts of drug development that involve evaluations of drug safety, bioequivalence, and pharmacokinetics, and RBA data quality directly impacts the reliability of such assessments. RBA Method Validation requires compliance with various national method validation guidances, which will soon be superseded by harmonized guidance from the International Conference on Harmonisation (ICH). To ensure successful assay applications and regulatory submissions, bioanalytical methods are extensively evaluated and validated for accuracy/precision, selectivity, specificity, sensitivity, recovery, and stability under various operational conditions. Data generated for validation and sample analyses and all documentation necessary for reconstructing the validation study and sample analyses, (e.g. experimental data, protocols, reports, staff training records, SOPs, etc.) needs to be maintained and available for data audit and inspection.

Related Services:
Validated bioanalytical methods list

LC/MS/MS Methods, Immunoassay Biomarker Methods and LC/MS Biomarker Methods

Biotech Laboratory Solutions

For small and mid-size companies, we offer a set of flexible solutions that can be customized

Assay Development for Large-Scale Clinical Studies

Bioanalytical expertise to support large-scale, international studies

Read More